0 views
The Trump administration announced deals that will lower the prices of major obesity drugs for many Americans. Under the deals with Eli Lilly and Novo Nordisk, those buying injectable GLP-1 medications directly from the companies will pay an average of $350 per month, but the drugmakers have committed to reducing the price to around $250 over the next two years, according to senior administration officials. If oral GLP-1 tablets are approved by the US Food and Drug Administration, the lowest dose will cost $149. #cnn #news #ozempic #wegovy #trump
Date: November 6, 2025
